Compass Therapeutics Inc. (NASDAQ: CMPX)
$1.4900
-0.0200 ( -1.97% ) 85.0K
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.
Market Data
Open
$1.4900
Previous close
$1.5100
Volume
85.0K
Market cap
$206.38M
Day range
$1.4800 - $1.5600
52 week range
$0.7650 - $2.3400
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 16 | Dec 10, 2024 |
4 | Insider transactions | 1 | Dec 10, 2024 |
3 | Insider transactions | 1 | Dec 10, 2024 |
3 | Insider transactions | 2 | Dec 10, 2024 |
10-q | Quarterly Reports | 62 | Nov 12, 2024 |
8-k | 8K-related | 15 | Nov 12, 2024 |
4 | Insider transactions | 1 | Aug 14, 2024 |
10-q | Quarterly Reports | 60 | Aug 12, 2024 |
8-k | 8K-related | 15 | Aug 12, 2024 |
3 | Insider transactions | 2 | Aug 09, 2024 |